ZYME ▼ -0.8% - Zymeworks Inc. $ZYME - Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026 24-OCT-2026 02:30 AM ET